title: Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia.
abstract: Niaspan, when added to a stable dose of a statin in 66 subjects, was found to be safe and highly effective in improving lipid parameters. Subgroup analyses demonstrated its effectiveness in lowering low-density lipoprotein cholesterol in persons not at the National Cholesterol and Education Program low-density lipoprotein cholesterol target and in raising high-density lipoprotein cholesterol in persons with levels < 40 mg/dl.
authors.affiliation: Department of Medicine, University of Pennsylvania Health System, Philadelphia, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Wolfe
authors.forename: S F
authors.initials: SF
authors.lastname: Vartanian
authors.forename: J L
authors.initials: JL
authors.lastname: Ross
authors.forename: L L
authors.initials: LL
authors.lastname: Bansavich
authors.forename: E R
authors.initials: ER
authors.lastname: Mohler
authors.forename: E
authors.initials: E
authors.lastname: Meagher
authors.forename: C A
authors.initials: CA
authors.lastname: Friedrich
authors.forename: D J
authors.initials: DJ
authors.lastname: Rader
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D009525:Niacin